| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT02411448 | A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated… | Metastatic Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07477457 | A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard… | Osteosarcoma | Recruiting |
| NCT03040973 | Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to… | Advanced Solid Tumors Which Are cMET-dependent | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT03122717 | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT03333343 | Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC | EGFR-mutant Non-small Cell Lung Cancer | Active, Not Recruiting |